Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Chi Mei Stellate Ganglion Block Meniere's Disease Study

Also known as: Effect of Stellate Ganglion Block on Meniere's Disease, Stellate ganglion block Meniere study, 0.25mg fludiazine, 25mg diphenidol, 200mg tocopherol nicotinate, NCT01574313

Institution-led study

Primary source
Sponsor / Institution
Institution-led study
Program Type
Procedure/Rehab
Modality
Procedure/Rehab
Stage
Phase 4
Status
Completed
Target Gene
Route / Mode
Stellate ganglion block procedure; oral active comparator
Confidence
70%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
Taiwan
Population
adult, meniere-disease, vestibular
Trial IDs
1
Mechanism

Academic randomized study comparing stellate ganglion block with an oral-medication active comparator for Meniere's disease; the oral medications are comparator components, not distinct industry-sponsored pipeline programs.

Indications
Notes

Verified from ClinicalTrials.gov as a completed Chi Mei randomized study of stellate ganglion block versus one-dose oral medication comparator in Meniere's disease. The generated drug-arm fragments are collapsed into this procedure-level study record.

Evidence & Sources
2 structured sources
clinicaltrials
Supports: canonicalName, company, stage, status, modality, indications, trialIds, geography...
IDs: NCT01574313
Open
registry mirror
Supports: canonicalName, aliases, company, stage, status, modality, indications, trialIds...
IDs: NCT01574313, CMH09804-003, SGB09804-003
Open
Key Events
Clinical Trials (1)
Data Checks
merged-generated-intervention-armsinstitution-led-studyregistry-verified-studystudy-level-not-standalone-productprocedure-support-not-therapeutic-programnot-commercial-pipeline-program
Related Programs